SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001564590-21-055440
Filing Date
2021-11-09
Accepted
2021-11-09 07:09:46
Documents
65
Period of Report
2021-09-30

Document Format Files

Seq Description Document Type Size
1 10-Q cgem-10q_20210930.htm   iXBRL 10-Q 3579345
2 EX-31.1 cgem-ex311_8.htm EX-31.1 20380
3 EX-31.2 cgem-ex312_9.htm EX-31.2 20254
4 EX-32.1 cgem-ex321_7.htm EX-32.1 14716
  Complete submission text file 0001564590-21-055440.txt   11675452

Data Files

Seq Description Document Type Size
5 XBRL TAXONOMY EXTENSION SCHEMA cgem-20210930.xsd EX-101.SCH 60372
6 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE cgem-20210930_cal.xml EX-101.CAL 38649
7 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE cgem-20210930_def.xml EX-101.DEF 175983
8 XBRL TAXONOMY EXTENSION LABEL LINKBASE cgem-20210930_lab.xml EX-101.LAB 403185
9 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE cgem-20210930_pre.xml EX-101.PRE 309303
10 EXTRACTED XBRL INSTANCE DOCUMENT cgem-10q_20210930_htm.xml XML 2578827
Mailing Address ONE MAIN STREET SUITE 520 CAMBRIDGE MA 02142
Business Address ONE MAIN STREET SUITE 520 CAMBRIDGE MA 02142 617-410-4650
Cullinan Oncology, Inc. (Filer) CIK: 0001789972 (see all company filings)

IRS No.: 813867811 | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-39856 | Film No.: 211389842
SIC: 2836 Biological Products, (No Diagnostic Substances)